Bone mineral density and prediction of non-osteoporotic disease

Maturitas

Volumn 65, Issue 4, 2010, Pages 348-351

  Tremollieres, Florence ^a,b   Ribot, Claude ^a,b  

^a Paul Sabatier University   (France)

^b INSERM   (France)

Author keywords

BMD; Breast cancer; Cardiovascular diseases; Estrogenic status; Menopause; RANK RANK ligand osteoprotegerin system; Risk

Indexed keywords

CYTOKINE; LIPID; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SEX HORMONE;

ARTERY CALCIFICATION; ATHEROSCLEROSIS; BONE DENSITY; BONE DISEASE; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; ESTROGEN DEFICIENCY; FRAGILITY FRACTURE; HUMAN; LIPID BLOOD LEVEL; OSTEOPOROSIS; POSTMENOPAUSE; PREDICTION; PREDICTOR VARIABLE; REVIEW;

ATHEROSCLEROSIS; BONE DENSITY; BREAST NEOPLASMS; FEMALE; HUMANS; RISK FACTORS;

EID: 77649188155     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.12.023     Document Type: Review

References (57)

1. Ribot C., Pouilles J.M., Bonneu M., and Tremollieres F. Assessment of the risk of post-menopausal osteoporosis using clinical factors. Clin Endocrinol (Oxf) 36 (1992) 225-228
2. Eastell R. Role of oestrogen in the regulation of bone turnover at the menarche. J Endocrinol 185 (2005) 223-234
3. Berstein L., and Ross R.K. Endogenous hormones and breast cancer risk. Epidemiol Rev 15 (1993) 48-65
4. Cauley J.A., Lucas F.L., Kuller L.H., Vogt M.T., Browner W.S., and Cummings S.R. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures. J Am Med Assoc 276 (1996) 1404-1408
5. Zmuda J.M., Cauley J.A., Ljung B.M., Bauer D.C., Cummings S.R., and Kuller L.H. Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Natl Cancer Inst 93 (2001) 930-936
6. Zhang Y., Kiel D.P., Kreger B.E., et al. Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 336 (1997) 611-617
7. Nguyen T.V., Center J.R., and Eisman J.A. Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology study. Maturitas 36 (2000) 27-34
8. Buist D.S., LaCroix A.Z., Barlow W.E., et al. Bone mineral density and endogenous hormones and risk of breast cancer in postmenopausal women (United States). Cancer Causes Cont 12 (2001) 213-222
9. Ganry O., Tramier B., Fardellone P., Raverdy N., and Dubreuil A. High bone mass density as a marker for breast cancer in post-menopausal women. Breast 10 (2001) 313-317
10. Nelson R.L., Turyk M., Kim J., and Persky V. Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort. BMC Cancer 2 (2002) 22-31
11. Van der Klift M., de Laet E.D.H., Coebergh J.W.W., Hofman A., and Pols H.A.P. Bone mineral density and the risk of cancer: the Rotterdam study. Bone 32 (2003) 211-216
12. Ganry O., Baudoin C., Fardellone P., Peng J., and Raverdy N. Bone mass density and risk of breast cancer and survival in older women. Eur J Epidemiol 19 (2004) 785-792
13. Hadji P., Gottschalk M., Ziller V., Kalder M., Jackisch C., and Wagner U. Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT). Maturitas 56 (2007) 312-321
14. Chen Z., Arendell L., Aickin M., Cauley J., Lewis C.E., and Chlebowski R. Hip bone density predicts breast cancer risk independently of Gail score. Cancer 113 (2008) 907-915
15. Browner W.S., Pressman A.R., Nevitt M.C., and Cummings S.R. Mortality following fractures in older women. Arch Intern Med 156 (1996) 1521-1525
16. von der Recke P., Hansen M.A., and Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106 (1999) 273-278
17. Kado D.M., Browner W.S., Blackwell T., Gore R., and Cummings S.R. Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res 15 (2000) 1974-1980
18. Kiel D.P., Kauppila L.I., Cupples L.A., Hannan M.T., O'Donnel C.J., and Wilson P.W. Bone loss and the progression of abdominal aortic calcification over a 25-year period: the Framingham Heart Study. Calcif Tissue Int 68 (2001) 271-276
19. Tanko L.B., Bagger Y.Z., and Christiansen C. Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcif Tissue Int 73 (2003) 15-20
20. Stewart A., Kumar V., Torgerson D.J., Fraser W.D., Gilbert F.J., and Reid D.M. Axial BMD, change in BMD and bone turnover do not predict breast cancer incidence in early postmenopausal women. Osteoporos Int 16 (2005) 1627-1632
21. Trémollieres F.A., Pouiillès J.M., Laparra J., and Ribot C. Bone mineral density at menopause does not predict breast cancer indicence. Osteoporos Int 19 (2008) 1497-1504
22. Cummings S.R., Browner W.S., Bauer D.C., et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. N Engl J Med 339 (1998) 733-738
23. Ettinger B., Pressman A., Sklarin P., et al. Associations between low levels of serum estradiol, bone density and fractures among elderly women: the Study of Osteoporotic fractures. J Clin Endocrinol Metab 83 (1998) 2239-2243
24. Hesmati H.M., Khosla S., and Robins SP. Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. J Bone Miner Res 178 (2002) 172-178
25. Huang A.J., Ettinger B., Vittinghoff E., Ensrud K.E., Johnson K.C., and Cummings S.R. Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women. J Bone Miner Res 22 (2007) 1791-1797
26. Somner J., McLellan S., Cheung J., et al. Polymorphisms in the P450 c17 (17-hydroxylase/17,20-lyase) and P450 c19 (Aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J Clin Endocrinol Metab 89 (2004) 344-351
27. Dick I.M., Devine A., and Prince R.L. Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure and biochemistry in older women. Am J Physiol Endocrinol Metab 288 (2005) 989-995
28. Napoli N., Donepudi S., Sheikh S., Rini G.B., and Armamento-Villareal R. Increased 2-hydroxylation of estrogen in women with a family history of osteoporosis. J Clin Endocrinol Metab 90 (2005) 2035-2041
29. Muti P., Bradlow H.L., Micheli A., et al. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16α-hydroxyestrone ratio in premenopasual and postmenopausal women. Epidemiology 11 (2000) 635-640
30. Kristensen V.N., Harada N., Yoshimura N., et al. Genetic variants of CYP19 (aromatase) and breast cancer risk. Oncogene 19 (2000) 1329-1333
31. Kim J.Y., Lee C.S., Kim H.O., et al. The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women. Oncol Rep 22 (2009) 487-492
32. Riancho J.A., Valero C., Naranjo A., Morales D.J., Sanudo C., and Zarrabeitia M.T. Identification of an aromatase haplotype that is associated with gene expression and postmenopausal osteoporosis. J Clin Endocrinol Metab 92 (2007) 660-665
33. Masi L., Becherini L., Gennari L., et al. Polymorphism of the aromatase gene in postmenopasual Italian women: distribution and correlation with bone mass and fracture risk. J Clin Endocrinol Metab 86 (2001) 2263-2269
34. Riancho J.A., Zarrabeitia M.T., Valero C., et al. Aromatase gene and osteoporosis: relationship of the polymorphic loci with bone mineral density. Bone 36 (2005) 917-925
35. Chen C., Sakoda L.C., Doherty J.A., et al. Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China. Cancer Epidemiol Biomarkers Prev 17 (2008) 3457-3466
36. Zhang L., Gu L., Qian B., et al. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women. Breast Cancer Res Treat 114 (2009) 327-338
37. Cai Q., Kataoka N., Li C., et al. Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 17 (2008) 27-32
38. Tanko L.B., Christiansen C., Cox D.A., Geiger M.J., McNabb M.A., and Cummings S.R. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20 (2005) 1912-1920
39. Marcovitz P.A., Tran H.H., Franklin B.A., et al. Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol 96 (2005) 1059-1063
40. Magnus J.H., and Brussard Dl. Relationship between bone mineral density and myocardiola infarction in US adults. Osteoporos Int 16 (2005) 2053-2062
41. Varma R., Aronow W.S., Basis Y., et al. Relation of bone mineral density to frequency of coronary heart disease. Am J Cardiol 101 (2008) 1103-1104
42. Bredy P.L., Aronow W.S., Yoon J.H., Ahn C., and DeLuca A.J. Relation of bone mineral density to stress test-induced myocardial ischemia. Am J Cardiol 104 (2009) 199-201
43. Sennerby U., Melhus H., Gedeborg R., et al. Cardiovascular diseases and risk of hip fracture. JAMA 302 (2009) 1666-1673
44. Frost M.L., Grella R., Millasseau S.C., et al. Relationship of calcification of atherosclerotic plaque and arterial stifness to bone mineral density and osteoprotegerin in postmenopausal women referred for osteoporosis screening. Calcif Tissue Int 83 (2008) 112-120
45. Kim S.H., Kim Y.P., Cho M.A., et al. Echogenic carotid artery plaques are associated with vertebral fractures in postmenopausal women with low bone mass. Calcif Tissue Int 82 (2008) 411-417
46. Hyder JA, Allison MA, Barrett-Connor E, et al. Bone mineral density and atherosclerosis: The Multi-Ethnic Study of atherosclerosis, abdominal aortic calcium study. Atherosclerosis; doi:10.1016/j.atherosclerosis.2009.09.011.
47. Bagger Y.Z., Tanko L.B., Alexandersen P., Qin G., and Christiansen C. Radiographic measure of aorta calcification in a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med 259 (2006) 598-605
48. Hyder J.A., Allison M.A., Wong N., et al. Association of coronary artery and aortic calcium with lumbar bone density: the MESA abdominal aortic calcium study. Am J Epidemiol 169 (2009) 186-194
49. Bocchi L., Orso C.A., Passarello F., et al. Atherosclerosis of the vessels in the ligamentum teres. Optical and electron microscopy findings in elderly patients with femoral neck fractures. Ital J Orthop Traumatol 13 (1987) 365-369
50. Laroche M., Pouilles J.M., Ribot C., et al. Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin Rheumatol 13 (1994) 611-614
51. Gourdy P., Calippe B., Laurell H., et al. Role of inflammatory cytokines in the effect of estradiol on atheroma. Clin Exp Pharmacol Physiol 35 (2008) 396-401
52. Mazière C., Louvet L., Gomila C., Kamel S., Massy Z., and Mazière J.C. Oxidized low density lipoprotein decreases RANKL-induced differentiation of osteoclasts by inhibition of RANKL signalling. J Cell Physiol 221 (2009) 572-578
53. Almeida M., Ambrogini E., Han L., Manolagas S.C., and Jilka R.L. Increased lipid oxidation causes oxidative stress, increased peroxisome poliferator-activated receptor-gamma expression and diminished pro-osteogenic Wnt signalling in the skeleton. J Biol Chem 284 (2009) 27438-27448
54. Bucari N., Sarosi I., Dunstan C.R., et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12 (1998) 1260-1268
55. Panizo S., Cardus A., Encinas M., et al. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Circ Res 104 (2009) 1041-1048
56. Fan X., Roy E., Zhu L., et al. Nitric oxide regulates receptor activator of nuclear factor-κB ligand and osteoprotegerin expression in bone marrow stromal cells. Endocrinology 145 2 (2004) 751-759
57. Cummings S.R., San Martin J., McClung M.R., et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361 (2009) 365-756